Beijing

New Business

Unitree robotics profitable since 2020, eyes expansion amid high demand

Unitree Robotics, China’s leading manufacturer of robotic dogs, has maintained steady profitability since 2020 and has no immediate plans for…

Read More »
New Business

China hails untapped Asian partnerships amid protectionism, ‘external changes’

In the face of trade protectionism and rising global uncertainties, China and the entirety of Asia can find ways to…

Read More »
New Business

China’s industrial profits unexpectedly fall in ominous sign for economy

Profits at China’s industrial firms contracted at the start of 2025, flashing a worrying sign for the economy as higher…

Read More »
New Business

China, Europe ‘share same worry’ about unilateralism, can work together: ESM director

Europe and China have an opportunity to pave a path of multilateralism, as they share the same values for a…

Read More »
New Business

Jeffrey Sachs rejects US claims of Chinese overcapacity: ‘absolutely wrong’

A prominent American economist has dismissed claims China is deliberately cultivating industrial overcapacity as “absolutely wrong”, asserting the world needs…

Read More »
New Business

Why Trump’s Venezuela tariff move presents a dilemma for China

US President Donald Trump’s latest executive order enabling the United States to impose tariffs on any country that imports oil…

Read More »
New Business

For China’s private sector, Beijing’s long-sought decree seen as key to getting paid

Enough of China’s small enterprises have run up against insurmountable roadblocks in trying to collect payments for services rendered –…

Read More »
New Business

Chinese EV maker Xiaomi raises US$5.5 billion from share sale to accelerate expansion

Chinese tech firm Xiaomi raised HK$42.5 billion (US$5.5 billion) from a share sale to fund the expansion of its electric…

Read More »
New Business

Exclusive | Hong Kong must capitalise on DeepSeek to lure global and Chinese funds, HSBC says

The market rally driven by the DeepSeek breakthrough has attracted massive capital inflows to Hong Kong, as both international and…

Read More »
New Business

After China probe, is AstraZeneca’s new US$2.5 billion plan a blueprint for foreign firms?

Biopharmaceutical multinational AstraZeneca is not letting a bumpy 2024 dictate its path forward in China, and in the wake of…

Read More »
Back to top button